ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,575.42
0.32%
Dow Jones
44,025.81
1.24%
Gold vs US Dollar
2,761.935
0.64%
Brent Oil
78.945
0.25%
Bitcoin
105,079.84
-1.03%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Hepion Pharmaceuticals Inc (HEPA) Share Price

HEPA Hepion Pharmaceuticals Inc

0.3031
-0.0187 (-5.81%)
Pre Market
Last Updated: 09:18:01
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Hepion Pharmaceuticals Inc NASDAQ:HEPA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0187 -5.81 0.3031 0.3121 0.33 0.00 0.00  9,188 09:18:01   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -48.93M -7.0312 -0.05 2.24M
 Type  Size  Price  Time  Units 
 9 1 0.327 09:32:10 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HEPA News
13/01/202512:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
11/12/202413:26EDGAR2Form 8-K - Current report
11/12/202413:00GLOBEHepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
05/12/202413:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/12/202413:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/12/202413:00GLOBEHepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
21/11/202422:01EDGAR2Form 425 - Prospectuses and communications, business combinations
Period
Draw mode
Data Downloads for HEPA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Hepion Pharmaceuticals Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads